Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jinneng Science&Techology Co.,Ltd (603113.SS)
Dezhou, CN
Jinneng Science&Technology Co.,Ltd operates as an industrial enterprise with a strong emphasis on the energy sector. The company specializes in the production and supply of both fine chemical and coal-based chemical products across China. Its diverse portfolio includes key materials such as carbon black, coke, para cresol, sorbic acid and potassium, silica, methanol, and pure benzene. These products are integral to a variety of industrial applications, notably in tire manufacturing, as well as the iron, steel, pharmaceutical, and food processing industries. Furthermore, Jinneng Science&Technology Co.,Ltd extends its market reach internationally, exporting its goods to customers in Europe, North America, and Asia. Established in 1998, the company's headquarters are located in Dezhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -9.93% | -4.14% | +0.15% | -5.09% | +7.02% | +9.82% | +6.17% | -26.18% | -65.87% | -65.14% | -65.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+4.0% Q1'26: -25.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+137.1% ★ Q1'26: -975.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-0.5% Q1'26: -30.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+0.9% Q1'26: -18.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.2% Q1'26: -16.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+2.5% Q1'26: -10.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×6.82× Q1'26: -3.67× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.81B
est: 8.23B (+7.1%)
|
8.15B
est: 8.73B (-6.7%)
|
7.55B
est: 6.79B (+11.1%)
|
12.01B
est: 13.77B (-12.8%)
|
16.80B
est: 15.37B (+9.3%)
|
14.58B
est: 15.99B (-8.8%)
|
16.27B
est: 15.73B (+3.4%)
|
16.91B
est: 18.39B (-8.0%)
|
18.13B
18.13B – 18.13B
-1.4% YoY
|
18.54B
18.54B – 18.54B
+2.3% YoY
|
18.96B
18.96B – 18.96B
+2.3% YoY
|
| EBITDA |
1.81B
est: 881.59M (+105.3%)
|
1.25B
est: 935.69M (+33.4%)
|
1.50B
est: 727.74M (+106.1%)
|
1.69B
est: 1.48B (+14.7%)
|
1.12B
est: 1.65B (-32.3%)
|
991.55M
est: 1.71B (-42.1%)
|
993.94M
est: 1.24B (-20.1%)
|
1.00B
est: 1.45B (-31.2%)
|
1.43B
1.43B – 1.43B
-1.4% YoY
|
1.47B
1.47B – 1.47B
+2.3% YoY
|
1.50B
1.50B – 1.50B
+2.3% YoY
|
| EBIT |
1.50B
est: 466.45M (+221.5%)
|
907.49M
est: 495.07M (+83.3%)
|
1.06B
est: 385.04M (+175.8%)
|
1.17B
est: 780.72M (+50.3%)
|
362.92M
est: 871.24M (-58.3%)
|
252.43M
est: 906.30M (-72.1%)
|
106.84M
est: 478.28M (-77.7%)
|
150.65M
est: 559.11M (-73.1%)
|
551.23M
551.23M – 551.23M
-1.4% YoY
|
563.76M
563.76M – 563.76M
+2.3% YoY
|
576.66M
576.66M – 576.66M
+2.3% YoY
|
| Net Income |
1.27B
est: 1.92B (-33.9%)
|
762.33M
est: 961.49M (-20.7%)
|
889.21M
est: 1.01B (-11.8%)
|
925.81M
est: 1.61B (-42.4%)
|
249.17M
est: 1.20B (-79.2%)
|
137.38M
est: 512.20M (-73.2%)
|
-57.87M
est: 330.58M (-117.5%)
|
22.04M
est: 93.24M (-76.4%)
|
203.44M
203.44M – 203.44M
+118.2% YoY
|
288.20M
288.20M – 288.20M
+41.7% YoY
|
440.78M
440.78M – 440.78M
+52.9% YoY
|
| SGA |
360.01M
est: 37.19M (+867.9%)
|
388.47M
est: 39.48M (+884.1%)
|
198.59M
est: 30.70M (+546.8%)
|
282.10M
est: 62.25M (+353.1%)
|
236.16M
est: 69.47M (+239.9%)
|
213.55M
est: 72.27M (+195.5%)
|
214.16M
est: 214.43M (-0.1%)
|
47.78M
est: 250.67M (-80.9%)
|
247.14M
247.14M – 247.14M
-1.4% YoY
|
252.76M
252.76M – 252.76M
+2.3% YoY
|
258.54M
258.54M – 258.54M
+2.3% YoY
|
| EPS |
1.88
est: 2.14 (-12.1%)
|
1.13
est: 1.07 (+5.6%)
|
1.28
est: 1.12 (+14.1%)
|
1.11
est: 1.79 (-38.0%)
|
0.29
est: 1.33 (-78.2%)
|
0.16
est: 0.57 (-71.9%)
|
-0.07
est: 0.39 (-117.9%)
|
0.03
est: 0.11 (-76.4%)
|
0.24
0.24 – 0.24
+118.2% YoY
|
0.34
0.34 – 0.34
+41.7% YoY
|
0.52
0.52 – 0.52
+52.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets High Dividend Fund DEM | 0.00% | 132.8K | 0.63% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 104.0K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 38.9K | 0.29% |
| 4 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 12.7K | 0.26% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 5.6K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 624.8K | 0.06% |
| 7 | Vanguard Total International Stock ETF VXUS | 0.00% | 736.8K | 0.05% |
| 8 | Vanguard ESG International Stock ETF VSGX | 0.00% | 6.4K | 0.10% |
| 9 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 1.0K | 0.22% |
| 10 | Vanguard Total World Stock ETF VT | 0.00% | 37.2K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guoyong Yi | Deputy General Manager | — | male |
| Hongwei Liu | Deputy GM & Director | — | male |
| Jianwen Wang | Director & Deputy GM | — | male |
| Liangguang Bing | Deputy General Manager | — | male |
| Wenbin Gu | Director & MD | — | male |
| Zhongxia Wang | Board Secretary, Deputy GM, Chief Financial Officer & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603113.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
